Calif. Biotech Co. Dermira Debuts With $125M IPO
California-based biopharmaceutical company Dermira Inc. debuted on the public markets Friday with a $125 million initial public offering as it seeks to expand research and development of its potential treatments for...To view the full article, register now.
Already a subscriber? Click here to view full article